Literature DB >> 17515637

Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.

Hasan Nazik1, Betigül Ongen, Zayre Erturan, Melek Salcioğlu.   

Abstract

The purpose of this study was to type the Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates recovered from cystic fibrosis (CF) patients by random amplified polymorphic DNA (RAPD)-PCR and to determine the antibiotic susceptibility of these strains. P. aeruginosa (n=49), and S. maltophilia (n=11) isolates which had been recovered from 16 and 8 patients, respectively, during a 1-year period were investigated. Three primers were used for RAPD-PCR typing. Antibiotic susceptibility testing of all isolates was performed by the disc diffusion method. RAPD-PCR analysis revealed 21 (P. aeruginosa) and 9 (S. maltophilia) different genotypes. According to the antimicrobial susceptibility results, the P. aeruginosa and S. maltophilia strains were cumulated into 24 and 11 groups, respectively. The CF patients were colonized or infected with P. aeruginosa strains of single or sometimes multiple genotypes which remained stable over several months. Our results also revealed that cross-colonization might be possible among the patients who are followed up at the same center. Piperacillin-tazobactam for P. aeruginosa and trimethoprim-sulfamethoxazole for S. maltophilia were found to be the most active antibiotics according to our results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515637

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  8 in total

1.  Biofilm formation, antibiotic susceptibility and RAPD genotypes in Pseudomonas aeruginosa clinical strains isolated from single centre intensive care unit patients.

Authors:  Martina Vaněrková; Barbora Mališová; Iva Kotásková; Veronika Holá; Filip Růžička; Tomáš Freiberger
Journal:  Folia Microbiol (Praha)       Date:  2017-04-01       Impact factor: 2.099

2.  Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients.

Authors:  S Horster; L Bader; U Seybold; I Eschler; K G Riedel; J R Bogner
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

3.  Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.

Authors:  Arianna Pompilio; Stefano Pomponio; Valentina Crocetta; Giovanni Gherardi; Fabio Verginelli; Ersilia Fiscarelli; Giordano Dicuonzo; Vincenzo Savini; Domenico D'Antonio; Giovanni Di Bonaventura
Journal:  BMC Microbiol       Date:  2011-07-05       Impact factor: 3.605

4.  Development of an efficient conjugation-based genetic manipulation system for Pseudoalteromonas.

Authors:  Pengxia Wang; Zichao Yu; Baiyuan Li; Xingsheng Cai; Zhenshun Zeng; Xiulan Chen; Xiaoxue Wang
Journal:  Microb Cell Fact       Date:  2015-01-23       Impact factor: 5.328

5.  Antibiotic Resistance Patterns and Genetic Diversity in Clinical Isolates of Pseudomonas aeruginosa Isolated From Patients of a Referral Hospital, Isfahan, Iran.

Authors:  Hamid Vaez; Jamshid Faghri; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli; Mansour Sedighi; Hajieh Ghasemian Safaei
Journal:  Jundishapur J Microbiol       Date:  2015-08-01       Impact factor: 0.747

6.  Microscopic characterization of Pseudomonas Aeruginosa confines separate from clinical cases by testing RAPD-PCR method.

Authors:  Z Mahmmudi; A Emami; A A Gorzin
Journal:  J Med Life       Date:  2015

7.  Role of sul2 gene linked to transposase in resistance to trimethoprim/sulfamethoxazole among Stenotrophomonas maltophilia isolates.

Authors:  Li Fen Hu; Xi Hai Xu; Hai Fei Yang; Ying Ye; Jia Bin Li
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

8.  Antibiotic resistance and genotyping of gram-negative bacteria causing hospital-acquired infection in patients referred to Children's Medical Center.

Authors:  Setareh Mamishi; Shima Mahmoudi; Naimeh Naserzadeh; Reihaneh Hosseinpour Sadeghi; Mohammad Taghi Haghi Ashtiani; Abbas Bahador; Mohammad Reza Abdosalehi; Maryam Rahmani; Babak Pourakbari
Journal:  Infect Drug Resist       Date:  2019-10-29       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.